Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
atrial fibrillation
MedTech
Boston Scientific’s pulsed field ablation brings 125% EP growth
Boston Scientific boosted its financial outlook for 2024, after seeing a nearly 20% surge in the year-over-year sales of its cardiovascular devices.
Conor Hale
Jul 24, 2024 10:35am
Kardium nets $104M for its spherical pulsed field ablation probe
Jun 12, 2024 9:15am
FDA clears Galvanize's pulsed field ablation needle in cancer
May 28, 2024 2:05pm
J&J pulsed field ablation study shows 25% done with zero X-rays
May 21, 2024 11:30am
Medtronic nets Japan approval for pulsed field ablation system
May 13, 2024 11:25am
J&J brings AI update to its heart-mapping Carto 3 system
May 8, 2024 10:15am
